8-K

Company

IGC Pharma, Inc.

Filed

April 3, 2014

Period of Report

April 2, 2014

Accession Number

0001185185-14-000855

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →